MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
2024: ARPA-H announces awards to develop novel technologies for precise tumor removal
JHU (Johns Hopkins University)
Organization & Developments (Academia): JHU (Johns Hopkins University)
Office of Technology Transfer, JHU
*Portfolio Companies: JHU (Johns Hopkins)
Amplimmune
Organization & Developments: Amplimmune
Parents
Amplimmune
Children
2014: CEO of Gaithersburg-based biotech discusses why they chose a MedImmune buyout over an IPO
Amplimmune is a product driven company that is developing immune-based biologics to treat patients in the areas of cancer, autoimmunity, transplantation and infectious diseases.
Amplimmune's scientific founders from Johns Hopkins University have identified several key immunological ligands and receptors.
Hepatitis C
Jumps
*Key People: Amplimmune
Finance & Acquisitions: Amplimmune